We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00681330
Recruitment Status : Completed
First Posted : May 21, 2008
Last Update Posted : November 19, 2009
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Tokyo University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2009
  Study Completion Date : April 2009